Open an account

Cardlytics

CDLX · NASDAQ

$1.82−$0.025 (−1.36%)TodayMarket closed ·
Prev close $1.84

CDLX analyst rating

HoldConsensus of 1 analyst over the last 12 months. 0% rate it a buy.
  • Strong buy0
  • Buy0
  • Hold1
  • Underperform0
  • Sell0

12-month price target · 6 analysts

Average $6.12 (+237.2% upside)

Low
$4.04
Now
$1.82
High
$10.50

The case for and against

Updated Jul 10, 2025

Bull case

Cardlytics Inc is projected to experience improved fundamentals starting in the first quarter of the year, supported by enhanced execution and contributions from new advertisers, including a successful launch with American Express. The company's recent results exceeded expectations, driven by strong performance in the U.S. and U.K. segments, indicating positive engagement with advertisers and effective cost management. Furthermore, the constructive balance sheet position provides confidence in Cardlytics's ability to execute a turnaround, with prospects for growth and margin improvements anticipated as the company moves into 2025 and 2026.

Bear case

Cardlytics Inc. is facing a concerning outlook as its fourth-quarter billings fell to $116.3 million, representing an 11.9% year-over-year decline, compounded by a projected revenue drop of 11-16% year-over-year in the upcoming quarter. The anticipated billings of $91.5-$94.5 million in the first quarter indicate a continued negative trend, with a decline of 10-13% year-over-year, which, alongside ongoing model transitions and increased consumer redemptions, is adversely affecting key financial metrics such as GAAP revenue, adjusted contribution dollars, EBITDA, and cash flow. With the potential for longer-term resets in both growth and cash flow, self-funding for future growth appears increasingly challenging for the company amidst economic headwinds.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.